OS Therapies raises $7.2 million in gross proceeds from warrant exercises
OSTX•OS Therapies raised approximately $7.2 million in gross proceeds at the initial closing of a warrant exercise inducement and exchange offer. Seven holders exercised or pre-funded warrants covering 5,517,253 shares and received new warrants for the same number of shares.
1. Warrant offer closing
Seven holders exercised or pre-funded existing warrants covering 5,517,253 shares at $1.30 per share, or $1.299 per share for pre-funded warrants. They received new common stock purchase warrants covering 5,517,253 shares, exercisable at $1.40 per share. The offer expires at 11:59 p.m. Eastern time on October 30, 2026, unless extended or terminated earlier.
2. Use of proceeds
OS Therapies said net proceeds will support Herlystic regulatory filings, commercial preparations and general corporate purposes.
